Long-acting oral weekly risperidone (LYN-005) for schizophrenia in the USA (STARLYNG-1): a multicentre, open-label, non-randomised phase 3 trial ++...

https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(25)00135-X/fulltext?dgcid=hubspot_email_infocusalerts-psychiatry_feature&utm_campaign=infocusalerts-psychiatry&utm_medium=email&_hsenc=p2ANqtz-8idcQzGPjydfpqEs0VZq_thJNnOB7EF-9XmWxxrWgJpV3XjgXwrU1awouNqOTfGVKQ65SzH3vgvn8pE2fI-CnKwN8kkg&_hsmi=373110504&utm_content=372952145&utm_source=hs_email Editorial p475 Division and integration The Lancet Psychiatry https://www.thelancet.com/journals/lanpsy/issue/vol12no7/PIIS2215-0366(25)X0007-9 TheLancet.com will undergo maintenance on Sunday July 27th, from approximately, 5.30am to 1.30pm US EST. During this time, some of the site functionality will be paused, we apologise for the inconvenience.